Latest filing published 30 Jan 2025 for Apellis Pharmaceuticals, Inc., €7,870.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeffrey Eisele: trading record in brief
Jeffrey Eisele, listed as senior executive, appears in our data through filings on Apellis Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 23 December 2020 and 29 January 2025, the trades on record add up to 29 filings.
On the market, this insider has only sold: 15 sales, €1.4M in total. Outside the open market, there are 13 share grants. In 2025 alone, the filings show no purchases and 3 sales.
Most recently, on 30 January 2025, the filings show an open-market sale worth €7,870 in Apellis Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey Eisele
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 278 shares@ US$29.52360.6% of flowCommon StockSEC:0001127602-25-002379:0
- 1,291 shares@ US$30.42552.7% of flowCommon StockSEC:0001127602-25-001835:0
- 264 shares@ US$28.70210.5% of flowCommon StockSEC:0001127602-25-001193:0
- 63 shares@ US$33.090.1% of flowCommon StockSEC:0001127602-24-030106:0
- 279 shares@ US$64.13821.2% of flowCommon StockSEC:0001127602-24-002738:0
- 7,378 shares@ US$63.6931.0% of flowCommon StockSEC:0001127602-24-002012:0
- 1,607 shares@ US$64.9966.9% of flowCommon StockSEC:0001127602-24-001943:0
- 5,207 shares@ US$65.5822.5% of flowCommon StockSEC:0001127602-24-001603:0
- 19,508 shares0Common StockSEC:0001127602-24-001380:0
- 68 shares@ US$57.86090.3% of flowCommon StockSEC:0001127602-23-030552:0
- 1,646 shares@ US$68.767.7% of flowCommon StockSEC:0001127602-23-007327:0
- 9,886 shares0Common StockSEC:0000899243-23-005787:0
- 883 shares@ US$52.763.1% of flowCommon StockSEC:0001127602-23-002753:0
- 367 shares@ US$52.771.3% of flowCommon StockSEC:0001127602-23-002682:0
- 4,479 shares@ US$51.5815.2% of flowCommon StockSEC:0001127602-23-002172:0
- 2,033 shares@ US$52.057.0% of flowCommon StockSEC:0001127602-23-002128:0
- 22,580 shares0Common StockSEC:0001127602-23-001496:0
- 1,250 shares0Common StockSEC:0001127602-22-028239:0
- 434 shares@ US$38.5979.9% of flowCommon StockSEC:0001127602-22-002814:0
- 26,051 shares0Common StockSEC:0001127602-22-002061:0
- 89 shares@ US$47.8220.1% of flowCommon StockSEC:0001127602-21-031867:0
21 of 21 declarations
